Recently Featured

FDA Launches Drug Trials Snapshots Webpage to Enhance Transparency

July 7, 2026
The FDA has introduced the Drug Trials Snapshots webpage, a significant initiative aimed at increasing the availability and transparency of demographic data related to drug trials. This new platform is designed to provide stakeholders, including regulatory professionals, quality assurance experts, and supply chain managers, with critical insights into the diversity of clinical trial participants. Historically,…

Judge Temporarily Blocks Subpoenas in Criminal Probe of Transgender Care at New York Hospitals

July 7, 2026
NEW YORK — A federal judge has temporarily blocked prosecutors in Texas from accessing the medical records of transgender patients treated at New York hospitals, citing concerns over the potential misuse of sensitive information. Judge Katherine Polk Failla emphasized that the subpoenas were part of a broader, improper government initiative aimed at “demonizing and eradicating…

Novel Feeder Cell Line Dramatically Expands NK Cell Production

July 7, 2026
Researchers have developed an engineered feeder cell line, ARH-77, which significantly enhances the production of allogeneic natural killer (NK) cells, a promising avenue for adoptive cell therapy targeting cancer. Traditional production methods have struggled to yield NK cells in sufficient quantities for therapeutic use, with existing cell lines like K562 providing only modest expansion rates.…

Recoded E. coli Promises More Scalable Weight Loss Drug Production

July 7, 2026
The manufacturing of weight loss drugs at large scale could get cheaper and more sustainable thanks to an engineered strain of Escherichia coli (E. coli) bacteria. This fully recoded E. coli, designed to use only 61 codons to synthesize proteins, is now being rolled out as a new method for manufacturing peptides with non-natural chemistries,…

Ongoing Cases